Correlation between the expression of integrins in prostate cancer and clinical outcome in 1284 patients
Open Access
- 1 December 2014
- journal article
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 18 (6) , 343-350
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Survival Following Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiotherapy in Patients With Prostate Cancer: The Impact of Competing Causes of Mortality and Patient StratificationEuropean Urology, 2013
- Integrin signaling in control of tumor growth and progressionThe International Journal of Biochemistry & Cell Biology, 2013
- Circulating microRNAs as potential new biomarkers for prostate cancerBritish Journal of Cancer, 2013
- Her2/neu testing in gastric cancer: evaluating the risk of sampling errorsAnnals of Oncology, 2012
- βPix plays a dual role in cerebral vascular stability and angiogenesis, and interacts with integrin αvβ8Developmental Biology, 2012
- Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumorsBiology Open, 2012
- Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortiumInvestigational New Drugs, 2010
- Integrins in prostate cancer progressionEndocrine-Related Cancer, 2008
- Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 DegradationMolecular Cell, 2008
- Integrin trafficking and its role in cancer metastasisCancer and Metastasis Reviews, 2007